Apple's rumored plan to enter the smart glasses market by late 2026 is already reshaping the global AR optics supply chain, ...
The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results